ffi

TTK Healthcare
LIMITED
TTKH:SECL:GJ:02'l :16

February 03, 2016

BSE Limited

Fax No. 022-2272 312'l

Phiroze Jeejeebhoy Towers

Dalal Street
Mumbai 400 001

Company Code
Scrip Code

:
:

3153
507747

Dear Sirs,

Re: Unaudited Financial Results forthe Third

Quarter ended 313t December.2015

We are fonvarding herewith the Unaudited Financial Results for the Third euarter ended

31"r

December, 2015, approved by the Board of Directors of the Company at their Meeting held today.
Kindly take the above document on record

Thanking you

Yours faithfully
For TTK Healthcare Limited

fulil(S KALYANARAMAN)
Director t Secretary

Ercl.

: da

Regd Otfice . No. 6, Calhedral Road, Chennar - 6@ 086, INDIA

Phone : 91-44-28116106 - 08, Fax:9144-28116*7
Email : info@ttkhealthcare.com Website : www.ttkhalthcare.com
CIN : l-24231 TN 1 958P1C003647

(Factory:5. Old Trunk Road, Pallavararn Chennai - 600 043. INDIA)

ttk
TTK HEALTHCARE LIMITED
Rogd. Oftico

No.6, CathodralRoad, Chennai 000086

CIN: L2,I231TN1958PLC003647 W6bsite: www.hkhealthcare.com

STATEMENT OF UNAUDITEo FINANCIAL RESULTS FOR THE THIRO QUARTER AND NINE MONTHS ENDEo 3'lst DECEMBER, 2015

(Rs. in lakhs)

sl.

Palticulars

No.

I
I

12.
I

II
I
II

Expenses
(a) Cost of materials consumed
(b) Purchases of Stock-in-trade
(c) Changes in lnventories of finished goods, workin-progress and stock-in-trade
(d) Employee benefits expense
(e) Depreciation and amortisation expense
(0 Marketing Expenses
(o) Other expenses

Total Expenses
Profit / (Loss) from Operations before Other
lncome, Finance Costs and Exceptional ltems

Year to date figurs for

Current
period
ended

Previous

Previous

Yar ended

year ndEd

l?l,rzt2usl

(30/09/2015)

Unaudited

Unaudlted

'12682.63

12975.98

12079.44

39523.25

37085.07

48254.73

395.42
,13078.05

6.19
12982.17

3.43
12042.87

403.10
39926.35

17.58
37102.65

48292.66

864.48
4602.53

879.09
5074.31

867.07

2522.3',1

4988.28

196.01

-178.22

-350.19

2038.95
146.08
1925.65
2196.54
11970.21

2016.58
153.22
1987.14
2333.23
12265.35

1107.81

lncome from Operalions

(a) Net Sales / lncome from Operalions
(Net of Excise Duty)
(b) Other Operating lncome

Total income from ODerations (Net|

months
ended

Corresponding 3
Preceding 3
months
months
endEd ln the
ended
previous
year

(3',t

t12t20141 t31t12t20't s\ l31l'12t20141 (3't/03/2015)

Unaudited

I--

Unaudited

Audited

Unaudited

37.93
I

--

14421.70

2435.19
14849.00

3138.64
19063.03

326.60

-270.91

-256.89

6055.41

7228.44
613.98
7961.59
8202.96

45951.75

1826.49
130.55
1985.88
1eee.1ol
1'.t447.18

6503.24
6712.06
37396.68

5329.14
366.76
6605 89
6100.49
354'15.56

7'16.82

635.69

2529.67

1687.09

2340.91

124.94

139.55

151.01

398.69

455.38

656.78

1232.75

856.37

786.70

2928.36

2142.47

2997.69

71.49

71.98

94.13

218.59

267.86

364.23

'fi6't.66

784.39

692.57

2709.77

1874.61

2633.46

0.00

0.00

0.00

0.00

0.00

0.00

't161.66

784.39

692.57

2709.77

1874.61

2633.46

312.41

273.48

1037.52

715.89

1017.94

729.'.t1

47't.98

419.09

1672.25

't't58.72

't6't5.52

0.00
729.11

0.00
471.98

0.00

419.09

0.00
1672.25

0.00
115a.72

'1615.52

455.36

11-2]
4.

5.

Other lncome
Profit I (Loss) from Ordinary Activltles bsfore

Flnance Costs and Exceptional ttems (314)

16.
7

Finance Costs

Prorit / (Loss) from Ordinary Activities after

Finance Costs but betore Exceptlonal ltems
(516)

Exceptional ltems
Profit / (Loss) from Ordinary Activities before
Tax (7rB)
10. Tax Expense
11
Net Profit / (Loss) from Ordinary Activities after
Tax (9t'10)
12 Edraordinary ltems (Net of Tax Expenses)
13 Net Profit / (Loss)tor th poriod ('llt12)
14 Share of Profit / (Loss) ofAssociates
I 1s. Minority lnterest
16 Net Profit / (Loss) after taxes, minority interest
8

and share of profit / (loss) of associates

N.A.

0.00

N.A.
N,A,

729.1',1

471.98

776.60

776.60

419.09

1672.25

1158.72

16't5.52

('l3t14r'15)
17
18

Paid-up Equity Share Capital (Face Value Rs.10/pe. share)

Reserve excluding Revaluation Reserves as per
Balance Sheet of previous accounting year

19 Earnings per share (beforE Extraordinary

(i) (of Rs.l0/- each) (not annualised):
(a) Basic
(b) ]D'bted

I
I

19

(iD
I

ltems)

Earnings per shar6 (aftor Extraordinary ltems)

(of Rs.l0/- each) (not annualised):
Basic
(b) Diluted

l(a

II

9.39
9.39

III

6.08
6.08

6.08
6.08

776.60

II

776.60

776.60

776.60
10604.00

5.40
5.40

21 .53

5.40
5.40

21.53
21.53

21

.53

II

14.92
14.92

20.80
20.80

14.92

20.80
20.80

14.92

('l

The above results have been reviewed by the Audit Committee and approved by the Board of Oirectors at its Meeting held on 3rd February,
2016, at Chennai.

(2)

The Statutory Audito6 of the Company have carried out Limited Review of the above Unaudited Financial Results in terms of
33 ofthe SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

(3)

The Other Operating lncome includes non-recurring income of Rs.3.25 crores (Net) earned from producl development trials conduc{ed for
Third Party.

(4) The previous yea/s figures

hav been regrouped and reclassilied, wherever necessary to conform to the current yea/s presentation.

(5) This Statement is also available on the website of BSE Limited (www.bseindia.com) and National Stock Exchange ol lndia

Limited

(r,w./w.nseindia.com) and also on the website ofthe Company (www.ttkhealthcare.com).

For TTK HEALTHCARE LIMITED

Place:
Date:

Chennai
20't6

VICE CHAIRMAN

&

TTK HEALTHCARE LIMITED

Regd. Offlce : No,6, Cathedral Road, Chennal 600 086
CIN: L24231TN1958PLC003647 W.bite: www.ttkh6althca.e.com

SEGMENTWISE REVENUE, RESI'LTS & CAPITAL EMPLOYED

(Rs. in lakhs

Corresponding 3
Preceding 3
months
months
ended in the
ended
previous
year

3 months

sl.

Particulars

No.

ended

t3't t12t20151 (30/09/2015)

[Jnaudited
1

Segment Revenue:
l{a) Pharmaceuticals
l(b) Medical Devices
(c) Consumer Products
(d)

It")

Foods
Printinq

Tolal
Less : lnter Segment Revenue
Net SalEs / lncome from Operations
2.
Segment Rsults: [Profit (+)/ Loss (-)
betore tax and Interest from each
(a)
(b)
(c)
(d)
(e)

Pharmaceuticals
Medical Devices
Consumer Products
Foods
Printing

Total
Less : lnterest
Less : Unallocable Expenses
(Net of Unallocable lncome)

Total Protit (+)/ Loss (-) before tax

3

Capital Employed
(Segment Assets - SegmGnt Liabilities)

Pharmaceuticals
[4 Medical
Devices
l(b)
(c)
l(d)
(e)

Consumer Producls
Foods
Printing

Total Capital Employed in Segments

Add : Unallocable Corporate Assets !9Sg
Unallocable Corporate Liabilities
Total Capital Employed ln Company

Unaudited
7075.49
597.31
3855.99
1432.18

6702.85

496.73
3989.63
1485.06
8.36

---I--

131t12t2014\

Year to date figures for

Current
perlod
ended
(3'.t t't2J20151

- Unaudited-f Unaudited
6411 .07
441.41

21405.25

3425.24
1380.92

12128.10
4259.57
58.82

1671.51

Previous
year ended

Previous
Year ended

$1t12J2014\

(31/03/2015)

Unaudited

Audited

20155.57
't
51 't .38
11083.74
4275.33
59.05
37085.07
0.00
37085.07

26275 27
1979.64
14215.38
5712.28

2510.23
301.89
-543.65
1236.83
26.25

'15.01

20.80

'12975.98
0.00
1297s.98

12079.44
0.00
12079.44

39523.25

719.6s

423.20

2237 .15

90.69

42.89

218.20

4.12
1419.33

163.78
8.29

135.12
291.17
6.04

821.89
25.77

't050.'t7

898.42

3459.55

7't.09

71.98

94.13

218.59

1760.13
't78.13
-392.34
945.64
19.38
2510.94
267.86

'186.58

193.80

111.72

531.19

368.47

533.86

1't61.66

784.39

692.57

2709.77

1874.6',1

2633.46

r2682.63
0.00
12682.63

IIT
832.52

46.35
7

4.33

462.01

0.00
3S523-25

156.54

As on

As on

As on

As on

31t142015

31112J2014

3'.t t't2t2015

478.72
1186.33
-124.86
8546.22
-46.76
10039.65

30/09/2015
736.27
1269.24
-300.92
8230.08
-43.85
9890.82

9010.08

-124.46
8546.22
-46.76
10039.55

6342.02

7116.'t3

717 4.32

6342.02

t.67

17006.95

16184.40

16381.67

1638

1092.57
1227.86
-350.42
7062.89

478.72

48254.73
0.00
48254.73

353't.55
364.23

As on

As on

31t12t20,t1
1092.57
1227.86
-350.42
7062.89
-22.82

90't0.08

3'.103t2015
1048.98
1228.77
-253.16
?700.97
-21.10
9704.46

717 4.32

6782.55

't6184.40

164A7.01

1.

2.
3.

Segments have been identified in line with the Accounting Standard on Segment Reporting (AS-17) considering the organisation
struc{ure and the dilferential risks and retums ofthese segments.
Segmnt Sales i5 net of Excise Outy related to the Sales of own manufaciured goods for the current as well as for the previous
periods.
Details of producls included in each oI th Segments are as below :

Pharmaceuticals include producis for both Human and Veterinary use.

lt also includes OTC Brands like Woodward's

Gripewater distributed by the Consumer Products Division.

&
{.

Medical Devices include Artificial Hearl Valves, Orthopaedic lmplants, etc.

Consumer Products comprise of marketing and distribution of EVA Range of Cosmetics, Good Home range ol Scrubbers,
Freshners, etc., (Own Brands) and also trading of Branded Condoms.

.i.

Foods comprise of manulacturing and marketing of Food Products

Printing comprise of Printing and Publishing of Maps and Atlases.

4.

The segment-wise revenue, results and capital employed figures relate to respective amounts directly identifiable to each of the
segments. The unallocable expendlture includes erpenses incured on common services at the corporate level and also those
expenses not identiflable to any specific segment.

5.

The previous yea/s figures have been regrouped and reclassified, wherever necessary to conform to the current yea/s
presentation.

For

trKtfE^Lr2B{u}rnEo

tPlace : Chennai

Oate

:F

2016

T T RAGHUNATHAN
EXECUTIVE VICE CHAIRMAN